Axonopathy is closely linked to the development of diabetic encephalopathy induced by type II diabetes (T2D). Berberine has been shown to cross the blood-brain barrier and holds promising effect for neuronal damage in diabetes.
Objective:
The present study investigated the protective effect and the underlying mechanism of berberine on neuronal axonopathy in both in vitro and in vivo models.
Methods:
High glucose/high fat diet and streptozotocin injection-induced T2D rat model was used. Berberine was administered p.o. to T2D rat model for 10 weeks. Morris water maze test, in vivo neuronal tracing, immunohistochemistry, and western blot analysis were performed to evaluate the protective effects of berberine in T2D-induced diabetic encephalopathy rats. Primary cultured neurons were used to further explore the underlying mechanisms in vitro.
Results:
Berberine dramatically reduced blood glucose and serum insulin levels and alleviated insulin resistance. Berberine significantly attenuated memory impairment, axonopathy, and tau hyperphosphorylation, and also restored PI3K/Akt/GSK3β signaling pathway in T2D rats. In vitro, berberine induced an increase in the phosphorylation of PI3K/Akt as well as GSK3β in high glucose-treated primary neurons. Furthermore, berberine-induced PI3K/Akt activation also resulted in the dephosphorylation of tau protein, which could improve axonal transport impairment in high glucose-treated primary neurons. Pretreated neurons with LY294002, an inhibitor of PI3K, partially blocked berberine-inhibited tau phosphorylation and berberine-activated PI3K/Akt signaling pathway.
Conclusions:
Berberine exerts the protective effect against cognitive deficits by improving tau hyperphosphorylation and the axonal damage through restoring PI3K/Akt/GSK3β signaling pathway.
PanA, SunQ, BernsteinAM, SchulzeMB, MansonJE, WillettWC, HuFB (2011) Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. Am J Clin Nutr94, 1088–1096.
2.
Roman-PintosLM, Villegas-RiveraG, Rodriguez-CarrizalezAD, Miranda-DiazAG (2016) Diabetic polyneuropathy in type 2 diabetes mellitus: Inflammation, oxidative stress, and mitochondrial function. J Diabetes Res2016, 3425617.
3.
VerdileG, FullerSJ, MartinsRN (2015) The role of type 2 diabetes in neurodegeneration. Neurobiol Dis84, 22–38.
4.
KullmannS, HeniM, HallschmidM, FritscheA, PreisslH, HaringHU (2016) Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiol Rev96, 1169–1209.
5.
HanX, MinM, WangJ, BaoZ, FanH, LiX, AdelusiTI, ZhouX (2018) Quantitative profiling of neurotransmitter abnormalities in brain, cerebrospinal fluid, and serum of experimental diabetic encephalopathy male rat. J Neurosci Res96, 138–150.
6.
NakataT, HirokawaN (2007) Neuronal polarity and the kinesin superfamily proteins. Sci STKE2007, pe6.
7.
FalnikarA, BaasPW (2009) Critical roles for microtubules in axonal development and disease. Results Probl Cell Differ48, 47–64.
8.
LeroyK, BrettevilleA, SchindowskiK, GilissenE, AutheletM, De DeckerR, YilmazZ, BueeL, BrionJP (2007) Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. Am J Pathol171, 976–992.
9.
ZhouY, LuoY, DaiJ (2013) Axonal and dendritic changes are associated with diabetic encephalopathy in rats: An important risk factor for Alzheimer’s disease. J Alzheimers Dis34, 937–947.
10.
ArnoldR, KwaiNC, KrishnanAV (2013) Mechanisms of axonal dysfunction in diabetic and uraemic neuropathies. Clin Neurophysiol124, 2079–2090.
11.
SuzukiC, OzakiI, TanosakiM, SudaT, BabaM, MatsunagaM (2000) Peripheral and central conduction abnormalities in diabetes mellitus. Neurology54, 1932–1937.
12.
SchmidtRE, DorseyDA, BeaudetLN, ParvinCA, ZhangW, SimaAA (2004) Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuraxonoal dystrophy. J Neuropathol Exp Neurol63, 450–460.
13.
SungJY, TaniJ, ChangTS, LinCS (2017) Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy. PLoS One12, e0171223.
14.
GratuzeM, El KhouryNB, TurgeonA, JulienC, MarcouillerF, MorinF, WhittingtonRA, MaretteA, CalonF, PlanelE (2017) Tau hyperphosphorylation in the brain of ob/ob mice is due to hypothermia: Importance of thermoregulation in linking diabetes and Alzheimer’s disease. Neurobiol Dis98, 1–8.
15.
KimB, FeldmanEL (2015) Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp Mol Med47, e149.
16.
LiuY, LiuF, Grundke-IqbalI, IqbalK, GongCX (2009) Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer’s disease. J Neurochem111, 242–249.
17.
LiuY, LiuF, Grundke-IqbalI, IqbalK, GongCX (2011) Deficient brain insulin signalling pathway in Alzheimer’s disease and diabetes. J Pathol225, 54–62.
18.
DeyA, HaoS, Wosiski-KuhnM, StranahanAM (2017) Glucocorticoid-mediated activation of GSK3beta promotes tau phosphorylation and impairs memory in type 2 diabetes. Neurobiol Aging57, 75–83.
19.
Clodfelder-MillerBJ, ZmijewskaAA, JohnsonGV, JopeRS (2006) Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes55, 3320–3325.
20.
YangY, MaD, WangY, JiangT, HuS, ZhangM, YuX, GongCX (2013) Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes. J Alzheimers Dis33, 329–338.
21.
KumarA, Ekavali, ChopraK, MukherjeeM, PottabathiniR, DhullDK (2015) Current knowledge and pharmacological profile of berberine: An update. Eur J Pharmacol761, 288–297.
22.
HuangM, ChenS, LiangY, GuoY (2016) The role of berberine in the multi-target treatment of senile dementia. Curr Top Med Chem16, 867–873.
23.
ChenQ, MoR, WuN, ZouX, ShiC, GongJ, LiJ, FangK, WangD, YangD, WangK, ChenJ (2017) Berberine ameliorates diabetes-associated cognitive decline through modulation of aberrant inflammation response and insulin signaling pathway in DM rats. Front Pharmacol8, 334.
24.
LiuX, ZhouJ, AbidMD, YanH, HuangH, WanL, FengZ, ChenJ (2014) Berberine attenuates axonal transport impairment and opathy induced by Calyculin A in N2a cells. PLoS One9, e93974.
25.
GodoyJA, ArrazolaMS, OrdenesD, Silva-AlvarezC, BraidyN, InestrosaNC (2014) Wnt-5a ligand modulates mitochondrial fission-fusion in rat hippocampal neurons. J Biol Chem289, 36179–36193.
MoranC, BeareR, PhanTG, BruceDG, CallisayaML, SrikanthV, Alzheimer’s Disease Neuroimaging Initiative (2015) Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology85, 1123–1130.
28.
XuW, LiuJ, MaD, YuanG, LuY, YangY (2017) Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats. PLoS One12, e0172477.
29.
LiuL, LiuJ, GaoY, YuX, XuG, HuangY (2014) Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets. Br J Pharmacol171, 3246–3254.
30.
LiuC, WangZ, SongY, WuD, ZhengX, LiP, JinJ, XuN, LiL (2015) Effects of berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in vivo. Biomed Res Int2015, 313808.
31.
PetrovaM, ProkopenkoS, ProninaE, MozheykoE (2010) Diabetes type 2, hypertension and cognitive dysfunction in middle age women. J Neurol Sci299, 39–41.
32.
BogushM, HeldtNA, PersidskyY (2017) Blood brain barrier injury in diabetes: Unrecognized effects on brain and cognition. J Neuroimmune Pharmacol12, 593–601.
33.
SharmaR, BurasE, TerashimaT, SerranoF, MassaadCA, HuL, BitnerB, InoueT, ChanL, PautlerRG (2010) Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice. PLoS One5, e13463.
34.
PintanaH, ApaijaiN, KerdphooS, PratchayasakulW, SripetchwandeeJ, SuntornsaratoonP, CharoenphandhuN, ChattipakornN, ChattipakornSC (2017) Hyperglycemia induced the Alzheimer’s proteins and promoted loss of synaptic proteins in advanced-age female Goto-Kakizaki (GK) rats. Neurosci Lett655, 41–45.
35.
ChiasseuM, Cueva VargasJL, DestroismaisonsL, Vande VeldeC, LeclercN, Di PoloA (2016) Tau accumulation, altered phosphorylation, and missorting promote neurodegeneration in glaucoma. J Neurosci36, 5785–5798.
36.
SangH, LuZ, LiY, RuB, WangW, ChenJ (2001) Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules. Neurosci Lett312, 141–144.
37.
HiguchiM, LeeVM, TrojanowskiJQ (2002) Tau and axonopathy in neurodegenerative disorders. Neuromolecular Med2, 131–150.
38.
MoreiraRO, CamposSC, SolderaAL (2013) Type 2 diabetes mellitus and Alzheimer’s disease: From physiopathology to treatment implications. Diabetes Metab Res Rev, doi: 10.1002/dmrr.2442.
39.
QuZS, LiL, SunXJ, ZhaoYW, ZhangJ, GengZ, FuJL, RenQG (2014) Glycogen synthase kinase-3 regulates production of amyloid-beta peptides and tau phosphorylation in diabetic rat brain. ScientificWorldJournal2014, 878123.
40.
GaoC, HolscherC, LiuY, LiL (2011) GSK3: A key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease. Rev Neurosci23, 1–11.
41.
ParkSA (2011) A common pathogenic mechanism linking type-2 diabetes and Alzheimer’s disease: Evidence from animal models. J Clin Neurol7, 10–18.
42.
Guerrero-BerroaE, SchmeidlerJ, BeeriMS (2014) Neuropathology of type 2 diabetes: A short review on insulin-related mechanisms. Eur Neuropsychopharmacol24, 1961–1966.
43.
ChatuphonprasertW, Lao-OngT, JarukamjornK (2013) Improvement of superoxide dismutase and catalase in streptozotocin-nicotinamide-induced type 2-diabetes in mice by berberine and glibenclamide. Pharm Biol52, 419–427.
LanJ, ZhaoY, DongF, YanZ, ZhengW, FanJ, SunG (2015) Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol161, 69–81.
46.
BhutadaP, MundhadaY, BansodK, TawariS, PatilS, DixitP, UmatheS, MundhadaD (2011) Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behav Brain Res220, 30–41.
47.
HamedSA (2017) Brain injury with diabetes mellitus: Evidence, mechanisms and treatment implications. Expert Rev Clin Pharmacol10, 409–428.
48.
Ramos-RodriguezJJ, Sanchez-SotanoD, Doblas-MarquezA, Infante-GarciaC, Lubian-LopezS, Garcia-AllozaM (2017) Intranasal insulin reverts central pathology and cognitive impairment in diabetic mother offspring. Mol Neurodegener12, 57.
49.
AvilaJ, PallasN, BolosM, SayasCL, HernandezF (2016) Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies. Expert Opin Ther Targets20, 653–661.
50.
BatchuluunB, InoguchiT, SonodaN, SasakiS, InoueT, FujimuraY, MiuraD, TakayanagiR (2014) Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells. Atherosclerosis232, 156–164.
51.
KhazimK, GorinY, CavaglieriRC, AbboudHE, FantiP (2013) The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo. Am J Physiol Renal Physiol305, F691–700.
